The management of metastatic hormone-sensitive prostate cancer (mHSPC) is evolving, with emerging combination strategies reshaping how clinicians approach care. This interactive Booster Quiz is designed to help you test and refine your knowledge of the latest clinical data for emerging regimens and guideline-driven approaches for optimizing care in mHSPC. Through engaging questions, you will explore how to apply expert guidelines to real-world decision-making and evaluate recent clinical data for emerging regimens, including AKT inhibitors and androgen receptor pathway inhibitor (ARPI) combinations. Through this interactive quiz, you will be able to: Get instant feedback on your answer selections See how your expertise compares with peers across disciplines Access a downloadable clinical trial pocket guide and a summary with key supporting evidence.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
99% of listed courses are free
298 of a sample of 300 are free · 416 courses listed here.
Collected from the provider’s public pages
Specialties served/covered
- Addiction Medicine
- Adolescent Medicine
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Dermatology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- General Operative Anesthesia
- General Pediatrics
- General Surgery
- Geriatric Medicine
- Gynecologic Oncology
- Health Equity & Inclusion
- Hematology
- Hospital Medicine
- Infectious Disease
- Interventional Cardiology
- Interventional Radiology
- Medical Genetics & Genomics
- Medical Leadership & Administration
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Musculoskeletal Oncology
- Nephrology
- Neurodevelopmental Disabilities
- Neurology
- Neuromuscular Medicine
- Nuclear Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Pain Medicine
- Patient Education & Health Literacy
- Patient Safety & Quality Improvement
- Pediatric Hematology-Oncology
- Pediatric Neurology
- Practice Management & Ethics
- Pulmonary Disease
- Radiation Oncology
- Regional Anesthesia & Acute Pain
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Thoracic Surgery
- Transplant Hepatology
- Urological Oncology
- Urology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pain & Palliative
- Pathology & Lab
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 0.25 credits
- MOC · Up to 0.25 points
- Commercial Support
-
ReleasedFeb 13, 2026
-
Last day to claim creditFeb 13, 2027 4 months left
-
Medscape, LLC Therapeutic Evolution in mHSPC: Analyzing Emerging Combinations and Outcomes
-
PVI, PeerView Institute for Medical Education New Kids on the Block in mHSPC: Personalising Approaches Through Emerging Precision Therapies
-
Answers in CME Inc. (AiCME) From Evidence to Impact: Leveraging the Latest Data to Elevate Standards and Patient Outcomes in mHSPC
-
PRIME Education, Inc. (PRIME®) Personalized Decision-Making for Patients With Advanced HSPC
-
PRIME Education, Inc. (PRIME®) Advancing mHSPC Management: From Clinical Guidelines to Emerging Biomarker-Directed Therapies
-
PRIME Education, Inc. (PRIME®) Precision Oncology in mHSPC: Translating Emerging Evidence Into Clinical Practice
